Filter By Industry
Filter By Tag

Newsroom

Corporate Ads Press releases

1 - 10 of 249 Press Releases

$112 Million Contract Backlog for Cycurion (N A S D A Q: CYCU) Enters Hyper-Growth Phase With, Strategic Acquisitions, & Exploding AI Cybersecurity
Apr 22, 2026
Six Major Catalysts Converge as $CYCU Transforms Into a Scalable, High-Margin Government Cybersecurity Platform With Massive Upside Potential. New Interview with CEO Kevin Kelly (Link Below)

Igniting High-Growth Expansion as Electrification Strategy and Infrastructure Dominance Converge; 88% Revenue Growth (N Y S E: MWG)
Apr 22, 2026
Explosive Revenue Growth, Strategic EV Pivot, and Deep Integration Into Singapore Mega Projects Position $MWG at the Center of a Multi-Billion-Dollar Construction Transformation

Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
Apr 21, 2026
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation

Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
Apr 16, 2026
Proprietary Stem Cell Platform Meets Institutional-Grade AI Infrastructure—Positioning $KALA at the Center of a Massive, Underserved $167B R&D Opportunity

AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
Apr 15, 2026
Breakthrough Regulatory Alignment Now Meets Cutting-Edge Robotic Brain Therapy—Positioning $NRXP at the Intersection of Pharma, AI, and National Defense

$7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
Apr 14, 2026
$BCBC is the Owner and Exclusive Licensor of Intellectual Property Consisting of Two US Patents for Digital Asset ATM Technology

Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
Apr 13, 2026
Positive Phase II Results, Ongoing Phase III Trial, and Cash Runway Into Late-2027 Positions Cardiol Therapeutics Inc. (N A S D A Q: CRDL) $CRDL for Transformational Growth

Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
Apr 08, 2026
$317M Revenue in 2025 with as SMS Traffic Increased from 13.9 Billion to 17.4 Billion Messages, for 25.18% Growth Reflecting Higher-Margin for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)

Igniting High-Growth Transformation With Launch of XMax AI Subsidiary, Leveraging Global Furniture Dominance to Enter Explosive AI Markets: XMax Inc
Apr 08, 2026
XMax Inc. (N A S D A Q: XWIN) $XWIN is an Established global furniture leader pivots aggressively into artificial intelligence, positioning for scalable, technology-driven revenue expansion while maintaining a strong core business foundation

Accelerating into Active Oil Production with over 100 Barrels per day now being produced as Dual-revenue engine begins Generating Cash Flow: $IBG
Apr 07, 2026
Innovation Beverage Group (N A S D A Q: IBG) $IBG combines premium beverage strength with emerging energy output, positioning for scalable growth, tightening float dynamics, and near-term revenue visibility


Page: 1 2 3 4 5 Next
Corporate Ads RSS Feed